178 related articles for article (PubMed ID: 28665687)
21. CAC1 knockdown reverses drug resistance through the downregulation of P-gp and MRP-1 expression in colorectal cancer.
Chen N; Kong Y; Wu Y; Gao Q; Fu J; Sun X; Geng Q
PLoS One; 2019; 14(9):e0222035. PubMed ID: 31504073
[TBL] [Abstract][Full Text] [Related]
22. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
Li T; Gao F; Zhang XP
Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885
[TBL] [Abstract][Full Text] [Related]
23. Genetic Variants That Predispose to DNA Double-Strand Breaks in Lymphocytes From a Subset of Patients With Familial Colorectal Carcinomas.
Arora S; Yan H; Cho I; Fan HY; Luo B; Gai X; Bodian DL; Vockley JG; Zhou Y; Handorf EA; Egleston BL; Andrake MD; Nicolas E; Serebriiskii IG; Yen TJ; Hall MJ; Golemis EA; Enders GH
Gastroenterology; 2015 Dec; 149(7):1872-1883.e9. PubMed ID: 26344056
[TBL] [Abstract][Full Text] [Related]
24. Squalene epoxidase promotes the chemoresistance of colorectal cancer via (S)-2,3-epoxysqualene-activated NF-κB.
Liu Q; Zhang Y; Li H; Gao H; Zhou Y; Luo D; Shan Z; Yang Y; Weng J; Li Q; Yang W; Li X
Cell Commun Signal; 2024 May; 22(1):278. PubMed ID: 38762737
[TBL] [Abstract][Full Text] [Related]
25. ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway.
Wang Z; Zhao X; Wang W; Liu Y; Li Y; Gao J; Wang C; Zhou M; Liu R; Xu G; Zhou Q
Int J Oncol; 2018 Nov; 53(5):2102-2110. PubMed ID: 30106136
[TBL] [Abstract][Full Text] [Related]
26. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
[TBL] [Abstract][Full Text] [Related]
27. ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield.
Ou J; Peng Y; Yang W; Zhang Y; Hao J; Li F; Chen Y; Zhao Y; Xie X; Wu S; Zha L; Luo X; Xie G; Wang L; Sun W; Zhou Q; Li J; Liang H
Nat Commun; 2019 Mar; 10(1):1078. PubMed ID: 30842415
[TBL] [Abstract][Full Text] [Related]
28. Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer.
Kim HG; Kim CW; Lee DH; Lee JS; Oh ET; Park HJ
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491980
[TBL] [Abstract][Full Text] [Related]
29. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
Ahn JY; Lee JS; Min HY; Lee HY
Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
[TBL] [Abstract][Full Text] [Related]
30. Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells.
Geng R; Tan X; Zuo Z; Wu J; Pan Z; Shi W; Liu R; Yao C; Wang G; Lin J; Qiu L; Huang W; Chen S
Chin J Cancer; 2017 Jul; 36(1):63. PubMed ID: 28756770
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.
Wang L; Jiang CF; Li DM; Ge X; Shi ZM; Li CY; Liu X; Yin Y; Zhen L; Liu LZ; Jiang BH
Oncotarget; 2016 Jan; 7(3):2660-71. PubMed ID: 26673620
[TBL] [Abstract][Full Text] [Related]
32. RNF38 enhances 5-Fluorouracil resistance in colorectal cancer by activating the Wnt pathway.
Long Y; Zhao Q; Huang Y
J BUON; 2021; 26(4):1246-1251. PubMed ID: 34564977
[TBL] [Abstract][Full Text] [Related]
33. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
34. Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.
Lin J; Feng J; Yang H; Yan Z; Li Q; Wei L; Lai Z; Jin Y; Peng J
Oncol Rep; 2017 Oct; 38(4):2293-2300. PubMed ID: 28849113
[TBL] [Abstract][Full Text] [Related]
35. Enhancing 5-Fluorouracil Efficacy in a Primary Colorectal Cancer by Long-lasting Calcium Supplementation.
Jeong KY; Park M; Kim IU; Sim JJ; Kim HM
Anticancer Res; 2017 Jun; 37(6):2959-2964. PubMed ID: 28551633
[TBL] [Abstract][Full Text] [Related]
36. CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer.
Delhorme JB; Bersuder E; Terciolo C; Vlami O; Chenard MP; Martin E; Rohr S; Brigand C; Duluc I; Freund JN; Gross I
Biomed Pharmacother; 2022 Mar; 147():112630. PubMed ID: 35051860
[TBL] [Abstract][Full Text] [Related]
37. Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity.
Edahiro K; Iimori M; Kobunai T; Morikawa-Ichinose T; Miura D; Kataoka Y; Niimi S; Wakasa T; Saeki H; Oki E; Kitao H; Maehara Y
Mol Cancer Res; 2018 Oct; 16(10):1483-1490. PubMed ID: 29866926
[TBL] [Abstract][Full Text] [Related]
38. HOXA13 contributes to gastric carcinogenesis through DHRS2 interacting with MDM2 and confers 5-FU resistance by a p53-dependent pathway.
Han Y; Song C; Wang J; Tang H; Peng Z; Lu S
Mol Carcinog; 2018 Jun; 57(6):722-734. PubMed ID: 29436749
[TBL] [Abstract][Full Text] [Related]
39. SPOCK1 silencing decreases 5-FU resistance through PRRX1 in colorectal cancer.
Qu YL; Liu XL; Zhao SY; Zhai XF
Pathol Res Pract; 2022 Jun; 234():153895. PubMed ID: 35462225
[TBL] [Abstract][Full Text] [Related]
40. Cysteine-rich intestinal protein 1 suppresses apoptosis and chemosensitivity to 5-fluorouracil in colorectal cancer through ubiquitin-mediated Fas degradation.
Zhang L; Zhou R; Zhang W; Yao X; Li W; Xu L; Sun X; Zhao L
J Exp Clin Cancer Res; 2019 Mar; 38(1):120. PubMed ID: 30850009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]